Viewing Study NCT02665650


Ignite Creation Date: 2025-12-24 @ 5:24 PM
Ignite Modification Date: 2026-02-25 @ 4:39 PM
Study NCT ID: NCT02665650
Status: COMPLETED
Last Update Posted: 2019-05-16
First Post: 2016-01-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of the Combination of AFM13 and Pembrolizumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
Sponsor: Affimed GmbH
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module